Physician profile
Nancy C Boatwright
NPI 1437230679
$1,102.13
in general payments reported to CMS, 2019-2025
13 companies · $24.02 in 2025
The $24.02 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $524 · 2022: $395 · 2023: $106 · 2024: $53.65 · 2025: $24.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $212.26 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $199.41 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $191.29 | 2021-2023 | |
| Novo Nordisk INC | $179.77 | 2021-2024 | Rybelsus, Ozempic |
| Janssen Products, LP | $86.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $53.33 | 2022 | |
| Janssen Pharmaceuticals, INC | $46.54 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $43.85 | 2021-2023 | Farxiga |
| Amarin Pharma, INC. | $24.15 | 2021 | |
| Medtronic, INC. | $24.02 | 2025 | Venaseal |
| Sandoz INC. | $14.77 | 2024 | Hyrimoz |
| Takeda Pharmaceuticals U.S.A., INC. | $14.38 | 2021 | |
| Lilly USA, LLC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Boatwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.